AAPL334.51+2.24 (+0.67%) ▲|ABBV261.68+4.56 (+1.77%) ▲|ABT102.73+0.78 (+0.77%) ▲|ACN194.40+10.50 (+5.71%) ▲|ADBE263.56+11.33 (+4.49%) ▲|AMAT426.19-30.30 (-6.64%) ▼|AMD495.42-20.71 (-4.01%) ▼|AMGN380.80+3.45 (+0.91%) ▲|AMT177.21-0.65 (-0.36%) ▼|AMZN253.96-2.82 (-1.10%) ▼|AVGO344.37-17.63 (-4.87%) ▼|AXP327.64+2.95 (+0.91%) ▲|BA209.92-0.54 (-0.25%) ▼|BAC59.40-3.30 (-5.26%) ▼|BKNG175.50+1.58 (+0.91%) ▲|BLK1,066.15-13.50 (-1.25%) ▼|BMY64.04+0.40 (+0.63%) ▲|BNY157.59-5.07 (-3.12%) ▼|BRK-B515.18+4.81 (+0.94%) ▲|C137.11-1.71 (-1.23%) ▼|CAT784.88-33.69 (-4.12%) ▼|CL88.27+1.47 (+1.69%) ▲|CMCSA24.89-0.32 (-1.25%) ▼|COF207.02-1.29 (-0.62%) ▼|COP136.34-1.01 (-0.74%) ▼|COST920.04+15.27 (+1.69%) ▲|CRM259.43+11.71 (+4.73%) ▲|CSCO110.31-1.82 (-1.62%) ▼|CVS95.76+1.10 (+1.16%) ▲|CVX211.80-2.26 (-1.06%) ▼|DE680.83+5.09 (+0.75%) ▲|DHR202.76+2.62 (+1.31%) ▲|DIS108.79+2.24 (+2.10%) ▲|DUK118.88-0.54 (-0.45%) ▼|EMR148.27-3.92 (-2.58%) ▼|FDX312.06+1.29 (+0.42%) ▲|GD357.32+1.42 (+0.40%) ▲|GE317.53-6.13 (-1.89%) ▼|GEV873.21-84.06 (-8.78%) ▼|GILD146.23+2.51 (+1.75%) ▲|GM87.09+1.47 (+1.72%) ▲|GOOG344.74+9.29 (+2.77%) ▲|GOOGL348.22+9.72 (+2.87%) ▲|GS989.32-39.86 (-3.87%) ▼|HD311.65+2.91 (+0.94%) ▲|HON201.22-1.15 (-0.57%) ▼|IBM249.31+6.02 (+2.47%) ▲|INTC97.54-5.41 (-5.25%) ▼|INTU339.28+17.71 (+5.51%) ▲|ISRG378.26+9.11 (+2.47%) ▲|JNJ267.06+1.48 (+0.56%) ▲|JPM350.09-6.14 (-1.72%) ▼|KO89.24+0.95 (+1.07%) ▲|LIN463.08-3.14 (-0.67%) ▼|LLY1,138.90+23.20 (+2.08%) ▲|LMT530.83+6.64 (+1.27%) ▲|LOW198.79+1.97 (+1.00%) ▲|LRCX274.88-23.34 (-7.83%) ▼|MA572.51+3.32 (+0.58%) ▲|MCD257.40+4.87 (+1.93%) ▲|MDLZ62.31-0.14 (-0.22%) ▼|MDT93.74+2.78 (+3.05%) ▲|META666.95+18.92 (+2.92%) ▲|MMM162.12-2.85 (-1.73%) ▼|MO70.60+1.62 (+2.34%) ▲|MRK144.64+0.71 (+0.49%) ▲|MS207.34-7.05 (-3.29%) ▼|MSFT507.36+11.73 (+2.37%) ▲|MU927.33-47.93 (-4.91%) ▼|NEE81.77-0.54 (-0.66%) ▼|NFLX80.41+3.01 (+3.89%) ▲|NKE37.05+0.25 (+0.68%) ▲|NOW142.45+9.92 (+7.48%) ▲|NVDA211.77-6.52 (-2.99%) ▼|ORCL143.52-6.77 (-4.50%) ▼|PEP136.41+0.09 (+0.07%) ▲|PFE27.74+0.02 (+0.07%) ▲|PG146.09+0.82 (+0.56%) ▲|PLTR173.86+6.63 (+3.96%) ▲|PM194.39+3.33 (+1.74%) ▲|QCOM180.40-1.57 (-0.86%) ▼|RTX195.05-2.64 (-1.33%) ▼|SBUX99.12+0.38 (+0.38%) ▲|SCHW107.25+0.00 (+0.00%) ▲|SO86.77-0.40 (-0.46%) ▼|SPG204.77-0.06 (-0.03%) ▼|T26.57+0.51 (+1.94%) ▲|TMO611.41+1.59 (+0.26%) ▲|TMUS182.41+0.08 (+0.04%) ▲|TSLA360.37-5.07 (-1.39%) ▼|TXN263.76-4.95 (-1.84%) ▼|UBER72.57+0.90 (+1.25%) ▲|UNH383.76+6.99 (+1.86%) ▲|UNP284.89+0.49 (+0.17%) ▲|UPS102.33+2.05 (+2.04%) ▲|USB62.62-0.23 (-0.36%) ▼|V374.27+3.82 (+1.03%) ▲|VZ51.33+0.72 (+1.43%) ▲|WFC88.60-1.69 (-1.87%) ▼|WMT109.53+2.38 (+2.22%) ▲|XOM164.53-1.46 (-0.88%) ▼|AAPL334.51+2.24 (+0.67%) ▲|ABBV261.68+4.56 (+1.77%) ▲|ABT102.73+0.78 (+0.77%) ▲|ACN194.40+10.50 (+5.71%) ▲|ADBE263.56+11.33 (+4.49%) ▲|AMAT426.19-30.30 (-6.64%) ▼|AMD495.42-20.71 (-4.01%) ▼|AMGN380.80+3.45 (+0.91%) ▲|AMT177.21-0.65 (-0.36%) ▼|AMZN253.96-2.82 (-1.10%) ▼|AVGO344.37-17.63 (-4.87%) ▼|AXP327.64+2.95 (+0.91%) ▲|BA209.92-0.54 (-0.25%) ▼|BAC59.40-3.30 (-5.26%) ▼|BKNG175.50+1.58 (+0.91%) ▲|BLK1,066.15-13.50 (-1.25%) ▼|BMY64.04+0.40 (+0.63%) ▲|BNY157.59-5.07 (-3.12%) ▼|BRK-B515.18+4.81 (+0.94%) ▲|C137.11-1.71 (-1.23%) ▼|CAT784.88-33.69 (-4.12%) ▼|CL88.27+1.47 (+1.69%) ▲|CMCSA24.89-0.32 (-1.25%) ▼|COF207.02-1.29 (-0.62%) ▼|COP136.34-1.01 (-0.74%) ▼|COST920.04+15.27 (+1.69%) ▲|CRM259.43+11.71 (+4.73%) ▲|CSCO110.31-1.82 (-1.62%) ▼|CVS95.76+1.10 (+1.16%) ▲|CVX211.80-2.26 (-1.06%) ▼|DE680.83+5.09 (+0.75%) ▲|DHR202.76+2.62 (+1.31%) ▲|DIS108.79+2.24 (+2.10%) ▲|DUK118.88-0.54 (-0.45%) ▼|EMR148.27-3.92 (-2.58%) ▼|FDX312.06+1.29 (+0.42%) ▲|GD357.32+1.42 (+0.40%) ▲|GE317.53-6.13 (-1.89%) ▼|GEV873.21-84.06 (-8.78%) ▼|GILD146.23+2.51 (+1.75%) ▲|GM87.09+1.47 (+1.72%) ▲|GOOG344.74+9.29 (+2.77%) ▲|GOOGL348.22+9.72 (+2.87%) ▲|GS989.32-39.86 (-3.87%) ▼|HD311.65+2.91 (+0.94%) ▲|HON201.22-1.15 (-0.57%) ▼|IBM249.31+6.02 (+2.47%) ▲|INTC97.54-5.41 (-5.25%) ▼|INTU339.28+17.71 (+5.51%) ▲|ISRG378.26+9.11 (+2.47%) ▲|JNJ267.06+1.48 (+0.56%) ▲|JPM350.09-6.14 (-1.72%) ▼|KO89.24+0.95 (+1.07%) ▲|LIN463.08-3.14 (-0.67%) ▼|LLY1,138.90+23.20 (+2.08%) ▲|LMT530.83+6.64 (+1.27%) ▲|LOW198.79+1.97 (+1.00%) ▲|LRCX274.88-23.34 (-7.83%) ▼|MA572.51+3.32 (+0.58%) ▲|MCD257.40+4.87 (+1.93%) ▲|MDLZ62.31-0.14 (-0.22%) ▼|MDT93.74+2.78 (+3.05%) ▲|META666.95+18.92 (+2.92%) ▲|MMM162.12-2.85 (-1.73%) ▼|MO70.60+1.62 (+2.34%) ▲|MRK144.64+0.71 (+0.49%) ▲|MS207.34-7.05 (-3.29%) ▼|MSFT507.36+11.73 (+2.37%) ▲|MU927.33-47.93 (-4.91%) ▼|NEE81.77-0.54 (-0.66%) ▼|NFLX80.41+3.01 (+3.89%) ▲|NKE37.05+0.25 (+0.68%) ▲|NOW142.45+9.92 (+7.48%) ▲|NVDA211.77-6.52 (-2.99%) ▼|ORCL143.52-6.77 (-4.50%) ▼|PEP136.41+0.09 (+0.07%) ▲|PFE27.74+0.02 (+0.07%) ▲|PG146.09+0.82 (+0.56%) ▲|PLTR173.86+6.63 (+3.96%) ▲|PM194.39+3.33 (+1.74%) ▲|QCOM180.40-1.57 (-0.86%) ▼|RTX195.05-2.64 (-1.33%) ▼|SBUX99.12+0.38 (+0.38%) ▲|SCHW107.25+0.00 (+0.00%) ▲|SO86.77-0.40 (-0.46%) ▼|SPG204.77-0.06 (-0.03%) ▼|T26.57+0.51 (+1.94%) ▲|TMO611.41+1.59 (+0.26%) ▲|TMUS182.41+0.08 (+0.04%) ▲|TSLA360.37-5.07 (-1.39%) ▼|TXN263.76-4.95 (-1.84%) ▼|UBER72.57+0.90 (+1.25%) ▲|UNH383.76+6.99 (+1.86%) ▲|UNP284.89+0.49 (+0.17%) ▲|UPS102.33+2.05 (+2.04%) ▲|USB62.62-0.23 (-0.36%) ▼|V374.27+3.82 (+1.03%) ▲|VZ51.33+0.72 (+1.43%) ▲|WFC88.60-1.69 (-1.87%) ▼|WMT109.53+2.38 (+2.22%) ▲|XOM164.53-1.46 (-0.88%) ▼|
23.9 C
New York
Monday, September 14, 2026

Tag: report

newssourceFORcompanyinformationcontent1releasesmarket

AB to Report Second Quarter 2025 Results on July 24, 2025

NASHVILLE, Tenn., July 3, 2025 /PRNewswire/ -- AllianceBernstein L.P. and AllianceBernstein Holding L.P. (NYSE: AB) today announced that Second Quarter 2025 financial and operating results...

$7.80 Billion by 2030: Why Single-Use Surgical Instruments Are Reshaping Global Surgery | MarketsandMarkets™

DELRAY BEACH, Fla., July 3, 2025 /PRNewswire/ -- What's fueling the shift from sterilization to scalability? The global single-use surgical instruments market, valued at US$5.60 billion...

Services PMI® at 50.8%; June 2025 Services ISM® Report On Business®

Business Activity Index at 54.2%; New Orders Index at 51.3%; Employment Index at 47.2%; Supplier Deliveries Index at 50.3% TEMPE, Ariz., July 3, 2025 /PRNewswire/...

VIA RAIL TO HOLD ITS ANNUAL PUBLIC MEETING ON AUGUST 21, 2025

MONTREAL, July 3, 2025 /CNW/ - VIA Rail Canada (VIA Rail) invites the public to listen to its 2025 Annual Public Meeting (APM) to be...

New Product Safety Recalls

WASHINGTON, July 3, 2025 /PRNewswire/ -- The CPSC announces today the following recalls are posted in cooperation with the firms listed below. Recalls can...

CPSC Warns Consumers to Immediately Stop Using Bolloco Infant Bath Seats Due to Risk of Serious Injury or Death from Drowning; Violates Federal Standard...

WASHINGTON, July 3, 2025 /PRNewswire/ -- The U.S. Consumer Product Safety Commission (CPSC) is warning consumers to immediately stop using Bolloco Infant Bath Seats....

DeFi Development Corp. Purchases 17,760 SOL, Resumes SOL Accumulation Strategy

BOCA RATON, FL, July 03, 2025 (GLOBE NEWSWIRE) -- DeFi Development Corp. (Nasdaq: DFDV) (the “Company”) the first public company with a treasury strategy built to accumulate and compound Solana (“SOL”), announced today the purchase of 17,760 Solana (“SOL”) at an average purchase price of $153.10 and valued at approximately $2.72 million. Following the transaction, DeFi Development Corp. now holds a total of approximately 640,585 SOL and SOL equivalents, valued at approximately $98.1 million, inclusive of staking rewards.

Blüm Holdings Signs Agreement to Acquire Northern California Retail Dispensary

DOWNEY, Calif., July 03, 2025 (GLOBE NEWSWIRE) -- Blum Holdings, Inc. (OTCQB: BLMH) (the “Company,” “Blüm,” “Blüm Holdings,” “we” or “us”), a California-based publicly traded holding company and cannabis operator, announced today that it has signed a binding agreement to acquire majority of the membership interests in another licensed adult-use and medical cannabis dispensary in Northern California.

Fullpath Releases New Consumer Survey Report Revealing the Future of Tech and AI in Car Buying

TEL AVIV, Israel, July 3, 2025 /PRNewswire/ -- Fullpath, the automotive industry's AI-first Customer Data Platform (CDP), announced the release of its latest survey...

Clearmind Medicine Announces IRB Approval for Phase 1/2a Clinical Trial for Alcohol Use Disorder at Tel Aviv Sourasky Medical Center

Vancouver, Canada, July 03, 2025 (GLOBE NEWSWIRE) -- Clearmind Medicine Inc. (Nasdaq: CMND), (FSE: CWY0) (“Clearmind” or the "Company"), a clinical-stage biotech company focused on discovery and development of novel psychedelic-derived therapeutics to solve major under-treated health problems, today announced that it has received Institutional Review Board (IRB) approval from Tel Aviv Sourasky Medical Center (TASMC) in Tel Aviv, Israel, for its ongoing Phase 1/2a clinical trial evaluating CMND-100, a proprietary MEAI-based oral drug candidate, for the treatment of Alcohol Use Disorder (AUD). This approval will enable patient enrollment at TASMC, a leading clinical site in Israel, prior to commencing this first-in-human trial at the site.

Half yearly report on LVMH’s liquidity contract with ODDO BHF SCA

Paris, July 3rd, 2025

HIGHWOOD ASSET MANAGEMENT LTD. ANNOUNCES EXPANDED CREDIT FACILITY TO $140 MILLION, OPERATIONAL AND GUIDANCE UPDATE AND COMMENCEMENT OF 2H2025 DRILLING PROGRAM

/NOT FOR DISSEMINATION IN THE U.S. OR THROUGH U.S. NEWSWIRES/ CALGARY, AB, July 3, 2025 /CNW/ -  ...

Stuhini Highlights High-Grade Tungsten Potential at Ruby Creek

VANCOUVER, BC, July 3, 2025 /CNW/ - Stuhini Exploration Ltd. (the "Company" or "Stuhini") (TSX-V: STU and OTCQB: STXPF) is pleased to report the...

Invitation to Vitrolife Group’s presentation of the Q2 2025 interim report

GOTHENBURG, Sweden, July 3, 2025 /PRNewswire/ -- Vitrolife AB (publ) will publish its Q2 2025 interim report on Thursday, 17 July 2025 at 08:00...

- A word from our sponsors -

spot_img

Newsletter Signup

Name(Required)
Email(Required)
Privacy(Required)
This field is for validation purposes and should be left unchanged.
HomeTagsReport

Explore

Press Releases

News & Opinion

Living

Others

Follow us

© Copyright 2025. BusinessPressWire® / 14 Wall Street New York City NY 10005 +1 888-502-0266 / Disclaimers